Financials EBOS Group Limited

Equities

EBO

NZEBOE0001S6

Pharmaceuticals

End-of-day quote New Zealand S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
35.06 NZD +2.22% Intraday chart for EBOS Group Limited +1.07% -1.24%

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,715 3,493 5,284 7,388 7,041 6,775 - -
Enterprise Value (EV) 1 4,103 3,851 5,607 8,346 7,870 7,898 7,747 7,675
P/E ratio 24.3 x 19.6 x 27.2 x 30.6 x 25.6 x 21.9 x 22.9 x 19.7 x
Yield 3.09% 3.71% 2.68% 2.75% 2.96% 3.35% 3.23% 3.59%
Capitalization / Revenue 0.51 x 0.36 x 0.55 x 0.62 x 0.53 x 0.48 x 0.54 x 0.52 x
EV / Revenue 0.56 x 0.4 x 0.58 x 0.7 x 0.6 x 0.56 x 0.62 x 0.59 x
EV / EBITDA 15.5 x 11.9 x 14.6 x 17.2 x 12.5 x 11.8 x 12.1 x 11.1 x
EV / FCF 42.1 x 17.6 x - 47 x 24.9 x 34.3 x 18.2 x 20.3 x
FCF Yield 2.38% 5.69% - 2.13% 4.02% 2.91% 5.5% 4.93%
Price to Book 2.82 x 2.44 x 3.58 x 2.92 x 2.66 x 2.64 x 2.58 x 2.48 x
Nbr of stocks (in thousands) 160,483 161,639 163,579 189,383 191,604 193,232 - -
Reference price 2 23.15 21.61 32.30 39.01 36.75 35.06 35.06 35.06
Announcement Date 8/21/19 8/19/20 8/17/21 8/23/22 8/22/23 - - -
1NZD in Million2NZD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 7,342 9,593 9,652 11,952 13,223 13,989 12,438 13,079
EBITDA 1 264.9 324.6 385 486.3 628.9 666.6 639.2 693
EBIT 1 231.1 285.4 308.9 395.3 523.2 554.9 521.1 573.9
Operating Margin 3.15% 2.98% 3.2% 3.31% 3.96% 3.97% 4.19% 4.39%
Earnings before Tax (EBT) 1 204.5 251.8 275.8 328.8 403.5 446.9 426.6 479.7
Net income 1 145.9 177.8 194.3 225.6 273.8 313.7 296.2 340.9
Net margin 1.99% 1.85% 2.01% 1.89% 2.07% 2.24% 2.38% 2.61%
EPS 2 0.9513 1.101 1.187 1.275 1.436 1.603 1.531 1.777
Free Cash Flow 1 97.46 219.2 - 177.5 316.6 230 426 378.5
FCF margin 1.33% 2.29% - 1.49% 2.39% 1.64% 3.42% 2.89%
FCF Conversion (EBITDA) 36.79% 67.53% - 36.5% 50.35% 34.5% 66.64% 54.62%
FCF Conversion (Net income) 66.81% 123.26% - 78.69% 115.65% 73.33% 143.8% 111.03%
Dividend per Share 2 0.7150 0.8022 0.8649 1.071 1.087 1.174 1.134 1.259
Announcement Date 8/21/19 8/19/20 8/17/21 8/23/22 8/22/23 - - -
1NZD in Million2NZD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2020 S1 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 4,574 5,022 4,771 5,658 6,105 6,790 6,582 6,993 6,895
EBITDA 1 174.8 - 191.9 223.8 255.1 319.5 316.4 332.7 343.9
EBIT 1 137.4 - 153.9 182.2 207 249.7 278.9 276.1 288.2
Operating Margin 3% - 3.22% 3.22% 3.39% 3.68% 4.24% 3.95% 4.18%
Earnings before Tax (EBT) - - 137.6 - 164.9 212.8 195.4 - -
Net income 1 - - 96.91 109.8 - 146 - 144.7 160.4
Net margin - - 2.03% 1.94% - 2.15% - 2.07% 2.33%
EPS - - 0.5916 - - - 0.6840 - -
Dividend per Share 2 - - - 0.4774 - - - 0.5620 0.6058
Announcement Date 2/19/20 2/17/21 8/17/21 2/15/22 8/23/22 2/21/23 8/22/23 2/20/24 -
1NZD in Million2NZD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 388 358 323 958 828 1,124 972 900
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.463 x 1.103 x 0.84 x 1.97 x 1.317 x 1.685 x 1.52 x 1.299 x
Free Cash Flow 1 97.5 219 - 178 317 230 426 378
ROE (net income / shareholders' equity) 12% 12.7% 13.8% 12.4% 12% 12.4% 11.5% 12.6%
ROA (Net income/ Total Assets) 4.47% 4.68% 4.89% 4.47% 4.4% 5.47% 5.26% 5.81%
Assets 1 3,263 3,803 3,973 5,049 6,217 5,732 5,629 5,872
Book Value Per Share 2 8.200 8.870 9.030 13.30 13.80 13.30 13.60 14.10
Cash Flow per Share 2 0.8200 1.550 1.910 1.570 2.220 2.300 2.190 2.250
Capex 1 28.2 31.6 81.1 100 106 113 65.3 67
Capex / Sales 0.38% 0.33% 0.84% 0.84% 0.8% 0.81% 0.53% 0.51%
Announcement Date 8/21/19 8/19/20 8/17/21 8/23/22 8/22/23 - - -
1NZD in Million2NZD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
34.3 NZD
Average target price
37.99 NZD
Spread / Average Target
+10.75%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EBO Stock
  4. Financials EBOS Group Limited